Given the detrimental effects of the TGF-β1/Smad/Sp1 axis on synaptic function and cognition in AngII-related hypertension, targeting this pathway may offer a promising strategy for treating AngII-related hypertension associated cognitive dysfunction. This evidence concerns the gene TGFB1 and Hypertension.